Predictive AI Models Could Upend Early Detection of Neurodegenerative Diseases What if a single MRI scan could reveal your risk for Alzheimer’s disease long before any symptoms emerge? As neurodegenerative conditions rise worldwide, innovative solutions are more critical than ev... AI in healthcare Alzheimer's disease early detection MRI imaging neurodegenerative diseases NSF research predictive modeling
FDA Clears First Blood-Based Biomarker Test for Alzheimer's: What It Means for Patients and Providers Diagnosing Alzheimer’s disease could be as simple as a routine blood draw thanks to the FDA’s recent clearance of the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio test from Fujirebio. This innova... Alzheimer's biomarkers diagnostics FDA clearance Fujirebio neurodegenerative diseases plasma test